Three-dimensional models of the cervicovaginal epithelia to study host-microbiome interactions and sexually transmitted infections.


Journal

Pathogens and disease
ISSN: 2049-632X
Titre abrégé: Pathog Dis
Pays: United States
ID NLM: 101595366

Informations de publication

Date de publication:
27 08 2022
Historique:
received: 25 04 2022
revised: 14 06 2022
accepted: 02 08 2022
pubmed: 5 8 2022
medline: 31 8 2022
entrez: 4 8 2022
Statut: ppublish

Résumé

2D cell culture systems have historically provided controlled, reproducible means to analyze host-pathogen interactions observed in the human reproductive tract. Although inexpensive, straightforward, and requiring a very short time commitment, these models recapitulate neither the functionality of multilayered cell types nor the associated microbiome that occurs in a human. Animal models have commonly been used to recreate the complexity of human infections. However, extensive modifications of animal models are required to recreate interactions that resemble those in the human reproductive tract. 3D cell culture models have emerged as alternative means of reproducing vital elements of human infections at a fraction of the cost of animal models and on a scale that allows for replicative experiments. Here, we describe a new 3D model that utilizes transwells with epithelial cells seeded apically and a basolateral extracellular matrix (ECM)-like layer. The model produced tissues with morphologic and physiological resemblance to human cervical and vaginal epithelia, including mucus levels produced by cervical cells. Infection by Chlamydia trachomatis and Neisseria gonorrhoeae was demonstrated, as well as the growth of bacterial species observed in the human vaginal microbiota. This enabled controlled mechanistic analyses of the interactions between host cells, the vaginal microbiota, and STI pathogens. Affordable and semi high-throughput 3D models of the cervicovaginal epithelia that are physiologically relevant by sustaining vaginal bacterial colonization, and facilitate studies of chlamydial and gonococcal infections.

Identifiants

pubmed: 35927516
pii: 6655985
doi: 10.1093/femspd/ftac026
pmc: PMC9419571
pii:
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : R21 AI162006
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI158930
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI084044
Pays : United States

Informations de copyright

© The Author(s) 2022. Published by Oxford University Press on behalf of FEMS.

Références

Nat Rev Dis Primers. 2019 Nov 21;5(1):79
pubmed: 31754194
Biol Reprod. 2007 Dec;77(6):1049-59
pubmed: 17881767
Nat Biomed Eng. 2020 Apr;4(4):381-393
pubmed: 32251392
Nat Mater. 2007 Nov;6(11):908-15
pubmed: 17906630
Methods Mol Biol. 2010;659:323-36
pubmed: 20809324
J Infect Dis. 2016 Aug 15;214 Suppl 1:S6-S13
pubmed: 27449872
Infect Immun. 2008 Jul;76(7):3124-30
pubmed: 18411284
Front Microbiol. 2019 Jul 31;10:1740
pubmed: 31417529
Methods Mol Biol. 2019;1997:413-429
pubmed: 31119637
Int J STD AIDS. 2003 Feb;14(2):109-13
pubmed: 12662389
Hum Reprod. 2001 Sep;16(9):1809-13
pubmed: 11527880
Am J Reprod Immunol. 2014 Jun;71(6):618-23
pubmed: 24661416
J Vis Exp. 2012 Apr 03;(62):
pubmed: 22491366
BMC Microbiol. 2016 Dec 3;16(1):286
pubmed: 27914477
Immunology. 2003 Jul;109(3):398-406
pubmed: 12807486
J Am Chem Soc. 2005 Oct 12;127(40):13788-9
pubmed: 16201789
Trends Biotechnol. 2021 Aug;39(8):788-810
pubmed: 33541718
Nat Commun. 2019 May 13;10(1):2144
pubmed: 31086185
FASEB J. 2021 Apr;35(4):e21463
pubmed: 33689188
MRS Commun. 2019 Jun;9(2):421-432
pubmed: 31485382
Infect Immun. 2017 Dec 19;86(1):
pubmed: 29038126
Anaerobe. 2017 Jun;45:10-18
pubmed: 28456518
Biol Reprod. 2020 May 26;102(6):1191-1202
pubmed: 32232331
Infect Immun. 2018 Oct 25;86(11):
pubmed: 30181350
Cell Microbiol. 2013 Jun;15(6):1042-57
pubmed: 23279089
Methods. 2011 Oct;55(2):114-21
pubmed: 21996033
Infect Immun. 2017 Feb 23;85(3):
pubmed: 28052997
Cell Microbiol. 2010 Feb;12(2):174-87
pubmed: 19811502
Mol Pharm. 2014 Jul 7;11(7):2082-91
pubmed: 24628276
Oncotarget. 2017 Feb 28;8(9):15267-15282
pubmed: 28146426
Am J Physiol. 1981 Oct;241(4):G275-88
pubmed: 7032321
J Reprod Immunol. 2011 Dec;92(1-2):8-20
pubmed: 21943934
Annu Rev Microbiol. 2012;66:371-89
pubmed: 22746335
ISME J. 2014 Dec;8(12):2431-44
pubmed: 25036926
J Cell Sci. 2003 Jun 15;116(Pt 12):2377-88
pubmed: 12766184
Hum Reprod. 2000 Apr;15(4):778-84
pubmed: 10739819
J Infect Dis. 1989 Apr;159(4):661-9
pubmed: 2926160
Am J Pathol. 1992 Apr;140(4):927-36
pubmed: 1562052
PLoS One. 2014 Mar 27;9(3):e93419
pubmed: 24676219
mSphere. 2015 Nov 18;1(1):
pubmed: 27303677
mBio. 2019 Aug 13;10(4):
pubmed: 31409678
Nature. 2003 Aug 21;424(6951):870-2
pubmed: 12931155
J Virol. 2019 May 1;93(10):
pubmed: 30842333
Front Microbiol. 2016 Dec 08;7:1936
pubmed: 28008325
Trends Microbiol. 2003 Dec;11(12):562-9
pubmed: 14659688
Nat Rev Microbiol. 2010 Nov;8(11):791-801
pubmed: 20948552
Am J Phys Anthropol. 2013 Dec;152 Suppl 57:119-34
pubmed: 24166771
Microbes Infect. 2014 Sep;16(9):735-45
pubmed: 24796635
Viruses. 2016 Aug 30;8(9):
pubmed: 27589787
AIDS. 2019 May 1;33(6):953-964
pubmed: 30946149
mBio. 2015 Oct 06;6(5):e01084-15
pubmed: 26443453
J Infect Dev Ctries. 2019 Sep 30;13(9):847-850
pubmed: 32074096
AIDS Res Hum Retroviruses. 2019 Mar;35(3):219-228
pubmed: 30638028
Vet Res Commun. 2018 Dec;42(4):255-263
pubmed: 30117040
J Biomed Res. 2017 Jan 19;31(3):240-247
pubmed: 28808216
Pathog Dis. 2016 Mar;74(2):
pubmed: 26676260
Front Cell Infect Microbiol. 2017 Feb 03;7:18
pubmed: 28217555
Front Microbiol. 2019 Jan 14;9:3340
pubmed: 30692980
Infect Immun. 1999 Mar;67(3):1149-56
pubmed: 10024555
AIDS. 2018 Jan 2;32(1):1-10
pubmed: 29112072
Front Cell Infect Microbiol. 2017 Oct 10;7:438
pubmed: 29067282
Front Cell Infect Microbiol. 2018 Jan 18;8:1
pubmed: 29404279
Infect Immun. 1999 Jul;67(7):3469-80
pubmed: 10377128
Front Cell Infect Microbiol. 2014 Jun 03;4:72
pubmed: 24918090
mBio. 2019 Apr 23;10(2):
pubmed: 31015326
Cytokine. 2013 Aug;63(2):151-65
pubmed: 23673287
Am J Reprod Immunol. 2015 Sep;74(3):228-36
pubmed: 25989718
Biol Reprod. 2018 Oct 1;99(4):718-726
pubmed: 29767686
Mol Biol Evol. 1993 Nov;10(6):1327-42
pubmed: 8277858
Nat Commun. 2017 Mar 28;8:14584
pubmed: 28350383
J Clin Pathol. 1975 Nov;28(11):910-4
pubmed: 1236632
EBioMedicine. 2019 Jun;44:675-690
pubmed: 31027917
Transl Res. 2017 Feb;180:22-36
pubmed: 27543901
Biol Reprod. 2010 Mar;82(3):617-27
pubmed: 20007410
J Infect Dis. 2014 Jun 15;209(12):1989-99
pubmed: 24403560
PLoS One. 2013 Nov 06;8(11):e80074
pubmed: 24223212
Methods Mol Biol. 2019;1997:347-361
pubmed: 31119633
J Vet Med A Physiol Pathol Clin Med. 2006 May;53(4):185-93
pubmed: 16629952
Infect Immun. 1985 May;48(2):592-6
pubmed: 2985506
mBio. 2013 Aug 06;4(4):
pubmed: 23919998

Auteurs

Vonetta L Edwards (VL)

Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, United States.
Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, United States.

Elias McComb (E)

Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, United States.

Jason P Gleghorn (JP)

Department of Biomedical Engineering, University of Delaware, Newark, DE, United States.

Larry Forney (L)

Department of Biological Sciences, University of Idaho, Moscow, ID, United States.

Patrik M Bavoil (PM)

Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, United States.
Department of Microbial Pathogenesis, University of Maryland, Baltimore, MD, United States.

Jacques Ravel (J)

Institute for Genome Sciences, University of Maryland School of Medicine, Baltimore, MD, United States.
Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH